Use of vonoprazan for management of systemic sclerosis-related gastroesophageal reflux disease.

frequency scale for symptoms of gastroesophageal reflux disease gastroesophageal reflux disease proton pump inhibitor systemic sclerosis vonoprazan

Journal

Biomedical reports
ISSN: 2049-9434
Titre abrégé: Biomed Rep
Pays: England
ID NLM: 101613227

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 12 06 2020
accepted: 13 11 2020
entrez: 7 1 2021
pubmed: 8 1 2021
medline: 8 1 2021
Statut: ppublish

Résumé

Gastroesophageal reflux disease (GERD) in systemic sclerosis (SSc) can significantly reduce a patient's quality of life. GERD in SSc is occasionally resistant to conventional anti-acid treatment. Vonoprazan is an H

Identifiants

pubmed: 33408859
doi: 10.3892/br.2020.1401
pii: BR-0-0-01401
pmc: PMC7780750
doi:

Types de publication

Journal Article

Langues

eng

Pagination

25

Informations de copyright

Copyright: © Tabuchi et al.

Références

Rheumatol Int. 2012 Jan;32(1):165-8
pubmed: 20711592
Curr Treatm Opt Rheumatol. 2015 Mar 1;1(1):82-105
pubmed: 26005632
Reumatismo. 2011 Mar;63(1):5-10
pubmed: 21509344
Clin Exp Rheumatol. 2003;21(3 Suppl 29):S42-6
pubmed: 12889222
Aliment Pharmacol Ther. 2015 Apr;41(7):636-48
pubmed: 25707624
Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-225-7
pubmed: 25068521
BMC Gastroenterol. 2015 Feb 15;15:24
pubmed: 25888470
Aliment Pharmacol Ther. 2016 May;43(10):1048-59
pubmed: 26991399
J Gastroenterol Hepatol. 2009 Apr;24(4):633-8
pubmed: 19220681
Therap Adv Gastroenterol. 2017 Jun;10(6):439-451
pubmed: 28567114
Am J Gastroenterol. 1974 Oct;62(4):325-32
pubmed: 4432845
Semin Arthritis Rheum. 2006 Dec;36(3):173-81
pubmed: 17045629
Aliment Pharmacol Ther. 2006 Dec;24(11-12):1593-601
pubmed: 17206947
Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):115-121
pubmed: 26843456
Eur J Gastroenterol Hepatol. 1996 Mar;8(3):205-9
pubmed: 8724018
J Gastroenterol. 2004 Sep;39(9):888-91
pubmed: 15565409
Neurogastroenterol Motil. 2015 Feb;27(2):160-74
pubmed: 25469569
J Rheumatol. 2012 May;39(5):986-91
pubmed: 22382346
Aliment Pharmacol Ther. 2015 Sep;42(6):719-30
pubmed: 26193978
J Rheumatol. 1988 Feb;15(2):202-5
pubmed: 3361530
Therap Adv Gastroenterol. 2016 Nov;9(6):845-852
pubmed: 27803739
Toxicol Pathol. 1988;16(2):267-72
pubmed: 3187355
J Rheumatol. 1996 Feb;23(2):297-301
pubmed: 8882035
Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):63-69
pubmed: 27243115
Clin Pharmacol Ther. 2001 Nov;70(5):484-92
pubmed: 11719736
Nat Rev Dis Primers. 2015 Apr 23;1:15002
pubmed: 27189141
Dis Esophagus. 2008;21(4):355-63
pubmed: 18477259
J Gastroenterol Hepatol. 2019 Aug;34(8):1316-1328
pubmed: 30883868
J Gastroenterol Hepatol. 2012 Jul;27(7):1187-91
pubmed: 22414314
Br Med J. 1964 Jul 18;2(5402):177
pubmed: 14150898
Rheumatology (Oxford). 2008 Jun;47(6):746-52
pubmed: 18326539
Dis Esophagus. 2011 Jul;24(5):299-304
pubmed: 21166734
Digestion. 2017;95(2):156-161
pubmed: 28190016
Clin Exp Rheumatol. 2009 May-Jun;27(3 Suppl 54):15-21
pubmed: 19796556
Clin Exp Rheumatol. 2012 Mar-Apr;30(2 Suppl 71):S60-6
pubmed: 22691211
ISRN Rheumatol. 2011;2011:325826
pubmed: 22389793
Curr Rheumatol Rev. 2018;14(2):172-176
pubmed: 28443513
Nihon Rinsho. 2016 Aug;74(8):1351-1356
pubmed: 30562441
Neurogastroenterol Motil. 2016 Aug;28(8):1157-65
pubmed: 26921101

Auteurs

Maiko Tabuchi (M)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852-8501, Japan.

Hitomi Minami (H)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852-8501, Japan.

Yuko Akazawa (Y)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852-8501, Japan.
Department of Pathology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852-8501, Japan.

Miwa Ashida (M)

Department of Dermatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852-8501, Japan.

Toshihide Hara (T)

Department of Dermatology, Japan Community Healthcare Organization, Isahaya General Hospital, Isahaya, Nagasaki 854-8501, Japan.

Kunihiro Ichinose (K)

Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852-8501, Japan.

Moto Kitayama (M)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852-8501, Japan.

Keiichi Hashiguchi (K)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852-8501, Japan.

Kayoko Matsushima (K)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852-8501, Japan.

Naoyuki Yamaguchi (N)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852-8501, Japan.

Fuminao Takeshima (F)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852-8501, Japan.

Hisayoshi Kondo (H)

Division of Scientific Data Registry, Atomic Bomb Disease and Hibakusya Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, Japan.

Atsushi Kawakami (A)

Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852-8501, Japan.

Kazuhiko Nakao (K)

Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki 852-8501, Japan.

Classifications MeSH